Their findings demonstrated that Factor V Leiden (FVL) homozygosity and antiphospholipid syndrome (APS) antibodies were significantly more prevalent in first-trimester pregnancy losses, illustrating a heightened thrombotic risk early in gestation. This evidence concerns the gene F5 and antiphospholipid syndrome.